Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China
· Delayed Price · Currency is CNY 65.48
-0.43 (-0.65%)
Mar 9, 2026, 3:00 PM CST
Hangzhou Alltest Biotech Market Cap
Hangzhou Alltest Biotech has a market cap or net worth of 5.13 billion as of March 9, 2026. Its market cap has decreased by -6.61% in one year.
Market Cap
5.13B
Enterprise Value
2.68B
Revenue
911.30M
Ranking
n/a
PE Ratio
23.81
Stock Price
65.48
Market Cap Chart
Since March 25, 2021, Hangzhou Alltest Biotech's market cap has decreased from 9.38B to 5.13B, a decrease of -45.31%. That is a compound annual growth rate of -11.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.16B | 3.16% |
| Dec 31, 2025 | 5.00B | 1.91% |
| Dec 31, 2024 | 4.91B | -8.43% |
| Dec 29, 2023 | 5.36B | -2.86% |
| Dec 30, 2022 | 5.52B | -16.76% |
| Dec 31, 2021 | 6.63B | -29.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangxi Sanxin Medtec | 5.03B |
| Zhonghong Pulin Medical Products | 5.38B |
| SWS Hemodialysis Care | 4.88B |
| Qingdao NovelBeam Technology | 4.85B |
| Chimin Health Management | 4.65B |
| Well Lead Medical | 4.36B |
| Jiangsu Apon Medical Technology | 4.30B |
| QITIAN Technology Group | 6.33B |